NPI: 1528022720 · ALEXANDRIA, VA 22304 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,715 | $330K |
| 2019 | 18,833 | $155K |
| 2020 | 13,937 | $178K |
| 2021 | 6,479 | $82K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,077 | 753 | $696K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,808 | 734 | $33K |
| A4657 | Syringe, with or without needle, each | 2,501 | 741 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | 2,597 | 509 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,160 | 672 | $2K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 127 | 43 | $99.49 |
| 83970 | 442 | 216 | $56.25 | |
| 82728 | 496 | 252 | $33.91 | |
| 83550 | 465 | 235 | $21.41 | |
| 83540 | 464 | 234 | $16.18 | |
| 85048 | 912 | 478 | $13.03 | |
| 85041 | 915 | 478 | $11.98 |